News Focus
News Focus
icon url

Looping

03/20/15 8:45 PM

#95078 RE: Phoenix300 #95076

I agree. I don't think Leo is the type of guy to waste money. So far he has proven to be very cautious about spending.
I would assume the application fee for Nasdaq up listing is non refundable. Unless the application submitted is a total joke (and I don't believe that) then it has to go through. It will. It's coming.
Just a matter of time...short period now...imo.
icon url

CallMeCrazy

03/20/15 9:43 PM

#95080 RE: Phoenix300 #95076

I think you're right. The number 1 catalyst I'm looking for is the uplisting to the nasdaq. I think this sets the stage for other major announcements like a partnership or a FDA designation (hopefully breakthrough).

I don't believe Leo want to make a big announcement prior to uplisting and he has no control over when nasdaq will approve CTIX's application, however, Leo does have control over the timing of announcements like partnerships or FDA designations. Obviously, the price appreciation associated with these 2 announcements will be much greater after uplisting than before.

CTIX is playing to a tough investment audience and great clinical news notwithstanding, I think this audience wants to see further corroboration in the form of (1) uplisting, (2) partnership with "Big Pharma" and/or (3) FDA validation.

I think Leo could possibly have (2) and/or (3) in the bag and is merely waiting for (1) to happen.